[{"Assets_0_Q3_USD":1058985000.0,"CommonStockSharesConverted_0_Q3_shares":49464156.0,"CommonStockSharesOutstanding_0_Q3_shares":49464156.0,"EarningsPerShareBasic_1_Q3_USD":-1.34,"EarningsPerShareBasic_3_Q3_USD":-3.21,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-99734000.0,"NetIncomeLossConverted_1_Q3_USD":-66325000.0,"NetIncomeLossConverted_3_Q3_USD":-158102000.0,"RevenuesConverted_1_Q3_USD":460000.0,"RevenuesConverted_3_Q3_USD":30829000.0,"StockholdersEquity_0_Q3_USD":1017337000.0,"Ticker":"TPTX","CIK":"1595893","name":"TURNING POINT THERAPEUTICS, INC.","OfficialName":"Turning Point Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1579986704.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211109"}]